Janux Therapeutics (JANX) Current Assets: 2020-2025
Historic Current Assets for Janux Therapeutics (JANX) over the last 5 years, with Sep 2025 value amounting to $998.1 million.
- Janux Therapeutics' Current Assets rose 49.79% to $998.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $998.1 million, marking a year-over-year increase of 49.79%. This contributed to the annual value of $1.0 billion for FY2024, which is 195.97% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Current Assets is $998.1 million, which was down 0.74% from $1.0 billion recorded in Q2 2025.
- Over the past 5 years, Janux Therapeutics' Current Assets peaked at $1.0 billion during Q4 2024, and registered a low of $309.3 million during Q2 2023.
- Its 3-year average for Current Assets is $671.2 million, with a median of $661.9 million in 2024.
- As far as peak fluctuations go, Janux Therapeutics' Current Assets soared by 2,247.27% in 2021, and later decreased by 13.62% in 2023.
- Quarterly analysis of 5 years shows Janux Therapeutics' Current Assets stood at $377.0 million in 2021, then dropped by 11.82% to $332.4 million in 2022, then grew by 5.05% to $349.2 million in 2023, then skyrocketed by 195.97% to $1.0 billion in 2024, then spiked by 49.79% to $998.1 million in 2025.
- Its Current Assets was $998.1 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.0 billion in Q1 2025.